Therefore, we speculate that the better therapeutic effect of NaB in combination with a PD-1 inhibitor in glioma may be related to the increase in active antitumor substances in the metabolites of the gut microbiota and the decrease in substances that inhibit the function of T cells. This evidence concerns the gene PDCD1 and central nervous system cancer.